Kyowa Hakko to Highlight Cognitive Health at Complementary Medicines Australia Innovation Day 2026

Global ingredient supplier Kyowa Hakko will spotlight the growing relevance of cognitive health in the Australian supplement market at the Complementary Medicines Australia (CMA) Innovation Day 2026 in Sydney, Australia later this month. Danielle Citrolo, PharmD, chief operating officer and vice president of scientific and regulatory affairs, will host the session, “Cognizin: Premium Citicoline for Cognitive Performance and Long-Term Brain Health.”

CMA Innovation Day provides a forum for ingredient suppliers, brand owners, formulators, and retail buyers to discover the latest innovations shaping the market for vitamins, minerals, and supplements in Australia and the Asia-Pacific region.

Citrolo’s presentation will examine the science behind Cognizin and the mechanisms through which it supports cognitive health. Cognizin is the only citicoline ingredient to hold status with the Australian Therapeutic Goods Administration (TGA).

“Cognitive health is a rapidly growing priority for Australian consumers and the brands that serve them,” said Citrolo. “This presentation will give attendees a clear picture of the science behind Cognizin and why it represents a premium, differentiated ingredient for any brain health product strategy.”

Citrolo’s session will take place on May 21, 2026, at 2:35 p.m. AEST as part of Session 3: Innovating with Ingredients.